Quick check after trauma could spot PTSD risk early

NCT ID NCT05358067

Recruiting now Knowledge-focused Sponsor: Centre Hospitalier Arras Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a simple rating scale used by doctors right after a traumatic event can predict who will develop post-traumatic stress disorder (PTSD) later. Researchers will follow 241 adults who experienced a trauma in the last 48 hours, tracking their scores and checking for PTSD down the road. If the scale works, it could lead to a system where high-risk patients get a follow-up call to catch PTSD early and connect them to specialized care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If this works, doctors could use a quick rating scale to identify people at risk for PTSD right after a trauma, allowing early support and treatment.
What could go wrong: This is an observational study, not a treatment trial. The scale may not accurately predict PTSD, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST-TRAUMATIC STRESS DISORDER

Contacts and locations

Locations

Arras General Hospital
RECRUITING

Arras, 62000, France
Arras General Hospital
RECRUITING

Arras, 62000, France
Douai General Hospital
RECRUITING

Douai, 59507, France
Lens General Hospital
NOT_YET_RECRUITING

Lens, 62300, France
Lille University Hospital
RECRUITING

Lille, 59000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.